Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAn upset stomach on Wegovy is one of the most commonly reported experiences during the first weeks of treatment. Nausea, queasiness, loose stools or that unsettled feeling after eating affect a significant proportion of people starting semaglutide, particularly around dose increases. It is genuinely unpleasant — and if you are sitting with a queasy stomach right now wondering whether this is supposed to happen, you are far from alone. The short answer is: mild to moderate stomach upset with Wegovy is expected, usually temporary, and manageable. Serious symptoms are rarer but worth knowing. Semaglutide is a prescription-only medicine, and your prescriber is the right person to guide you through anything beyond routine discomfort — the information below is here to help you understand what you are experiencing while you decide whether to make that call.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You have stepped up to the next strength, you have eaten something ordinary (a sandwich, a bowl of pasta) and within an hour your stomach feels wrong. Not painful exactly, but heavy and unsettled. This is the scenario that prompts most questions about upset stomach on Wegovy, and it has a straightforward explanation.
Semaglutide slows gastric emptying: food moves through your stomach more slowly than it used to. That slowing is part of how the medicine reduces appetite, but it also means your digestive system needs time to recalibrate. The NHS semaglutide medicines page lists nausea, vomiting, diarrhoea, constipation, indigestion, burping and reflux as common effects, common meaning they affect at least one in ten people. These are not signs that something has gone wrong. They are signs that the medicine is active.
Dose increase weeks tend to be the flashpoint. People who tolerate 0.5mg or 1.0mg comfortably sometimes find the step to 1.7mg noticeably harder on the stomach. The same pattern holds at each rung. Symptoms usually peak within the first few days and settle (often considerably) before the next scheduled increase. Most people find that by the time they have been on a dose for a full four weeks, the stomach ache on Wegovy that arrived with it has largely faded.
If you are tracking your symptoms carefully, that context matters. A rough few days after stepping up is not a reason to stop, but it is a reason to let your prescriber know how you are getting on.
There is no single fix, but a cluster of practical changes tends to make a real difference. Smaller meals are the most consistently useful adjustment: a full plate takes longer to leave a slowed stomach, which amplifies that heavy, nauseous feeling. Eating until you are about 80% full rather than comfortably satisfied is a reasonable target while your body is adjusting.
Fatty and heavily spiced food are worth avoiding during the adaptation period, both are harder to digest and more likely to provoke reflux when gastric emptying is slower than usual. Plain, lower-fat options (oats, rice, boiled potato, lean protein) tend to sit better. Eating slowly, chewing thoroughly and not lying down for at least an hour after a meal also reduces the likelihood of reflux symptoms.
Hydration matters more than people expect. Nausea often worsens when you are mildly dehydrated, and if vomiting or diarrhoea is part of your picture, fluid replacement becomes genuinely important. Sipping water steadily through the day is easier on the stomach than drinking large amounts at once.
Timing the injection is worth experimenting with. Some people find that injecting in the evening means any peak nausea happens overnight when they are asleep rather than during the working day. There is no clinical mandate for a specific time of day (consistency matters more than the hour) but this practical adjustment is worth raising with your prescriber. If your symptoms feel less like general nausea and more like a full Wegovy stomach flu, that page explains why some people experience that pattern and what tends to help.
For a broader look at what stomach-related symptoms can look like over the course of treatment, the guide to Wegovy and stomach effects covers the full picture in more detail.
Most stomach upset on semaglutide is uncomfortable rather than dangerous. There are, however, symptoms that warrant medical attention rather than self-management.
Severe stomach pain (particularly pain that is persistent, does not respond to the usual remedies and radiates toward the back) should prompt you to contact a GP or call 111 without waiting. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis as a known, infrequent but serious side effect of GLP-1 receptor agonist medicines including semaglutide. Pancreatitis can be serious. The symptom profile is distinctive enough to be recognisable: it is not the general queasiness of early treatment, but a severe and persistent pain, sometimes accompanied by vomiting, that does not settle.
Gallbladder symptoms are also worth knowing about. Rapid weight loss of any kind can increase gallstone risk, and semaglutide has been associated with gallbladder-related events in clinical data. Right-sided upper abdominal pain, especially after eating fatty food, should be checked out. If you are also taking another medicine alongside semaglutide, it is worth checking whether that combination affects your risk profile, and our page on whether you can take Wegovy and Cosentyx together is one example of how those interactions can vary depending on what else you are prescribed.
Severe vomiting or diarrhoea that prevents you from keeping fluids down for more than 24 hours can lead to dehydration quickly enough to affect kidney function, another reason to seek advice early rather than waiting it out. If you have a more acute pain rather than general stomach upset, that page explains the distinction in more detail.
Any suspected side effect can be reported directly at the MHRA's Yellow Card scheme, a straightforward way to contribute to post-market safety monitoring for these medicines.
Stomach upset is one of the most common reasons people consider stopping Wegovy early, often before the medicine has had the chance to show what it can do. In many cases, a short conversation with a prescriber opens up options that were not obvious: slowing the titration schedule, adjusting injection timing, or simply having it confirmed that what you are experiencing is within the expected range.
There is also a cost dimension worth knowing about. If you are wondering whether different providers handle dose adjustments differently, or what ongoing clinical support looks like, the guide to accessing Wegovy in the UK covers private versus NHS routes and what responsible aftercare looks like in practice.
At nume, every patient has access to prescriber support seven days a week, not just at the point of first approval. Stomach symptoms are exactly the kind of thing our team hears about regularly, a question our prescribers field most weeks. If you are finding the adjustment difficult and want a clinical view on how to get through it, checking your eligibility is a good first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.